490 related articles for article (PubMed ID: 7860734)
21. Lassa fever virus peptides predicted by computational analysis induce epitope-specific cytotoxic-T-lymphocyte responses in HLA-A2.1 transgenic mice.
Boesen A; Sundar K; Coico R
Clin Diagn Lab Immunol; 2005 Oct; 12(10):1223-30. PubMed ID: 16210487
[TBL] [Abstract][Full Text] [Related]
22. Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.
Bondurant KL; Crew MD; Santin AD; O'Brien TJ; Cannon MJ
Clin Cancer Res; 2005 May; 11(9):3446-54. PubMed ID: 15867247
[TBL] [Abstract][Full Text] [Related]
23. Identification of a human CD8+ T lymphocyte neo-epitope created by a ras codon 12 mutation which is restricted by the HLA-A2 allele.
Bergmann-Leitner ES; Kantor JA; Shupert WL; Schlom J; Abrams SI
Cell Immunol; 1998 Aug; 187(2):103-16. PubMed ID: 9732698
[TBL] [Abstract][Full Text] [Related]
24. Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients.
Wang Y; Takao Y; Harada M; Komatsu N; Ono T; Sata M; Itoh K; Yamada A
Cell Immunol; 2006 May; 241(1):38-46. PubMed ID: 16963008
[TBL] [Abstract][Full Text] [Related]
25. Functionally distinct helper T-cell epitopes of HCV and their role in modulation of NS3-specific, CD8+/tetramer positive CTL.
Zhu F; Eckels DD
Hum Immunol; 2002 Sep; 63(9):710-8. PubMed ID: 12175725
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the CD8-positive T cell response in Japanese patients with chronic hepatitis C using HLA-A*2402 peptide tetramers.
Nakamoto Y; Kaneko S; Takizawa H; Kikumoto Y; Takano M; Himeda Y; Kobayashi K
J Med Virol; 2003 May; 70(1):51-61. PubMed ID: 12629644
[TBL] [Abstract][Full Text] [Related]
27. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis.
Rehermann B; Fowler P; Sidney J; Person J; Redeker A; Brown M; Moss B; Sette A; Chisari FV
J Exp Med; 1995 Mar; 181(3):1047-58. PubMed ID: 7532675
[TBL] [Abstract][Full Text] [Related]
28. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans.
Shirai M; Okada H; Nishioka M; Akatsuka T; Wychowski C; Houghten R; Pendleton CD; Feinstone SM; Berzofsky JA
J Virol; 1994 May; 68(5):3334-42. PubMed ID: 7512163
[TBL] [Abstract][Full Text] [Related]
29. Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition.
Kammer AR; van der Burg SH; Grabscheid B; Hunziker IP; Kwappenberg KM; Reichen J; Melief CJ; Cerny A
J Exp Med; 1999 Jul; 190(2):169-76. PubMed ID: 10432280
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.
Bertoletti A; Costanzo A; Chisari FV; Levrero M; Artini M; Sette A; Penna A; Giuberti T; Fiaccadori F; Ferrari C
J Exp Med; 1994 Sep; 180(3):933-43. PubMed ID: 7520476
[TBL] [Abstract][Full Text] [Related]
31. CD2/LFA-3 or LFA-1/ICAM-1 but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes.
de Waal Malefyt R; Verma S; Bejarano MT; Ranes-Goldberg M; Hill M; Spits H
Eur J Immunol; 1993 Feb; 23(2):418-24. PubMed ID: 7679643
[TBL] [Abstract][Full Text] [Related]
32. Generation of hepatitis C virus-specific cytotoxic T lymphocytes from healthy individuals with peptide-pulsed dendritic cells.
Ito A; Kanto T; Kuzushita N; Tatsumi T; Sugimoto Y; Miyagi T; Takehara T; Katayama K; Mochizuki K; Hiramatsu N; Kasahara A; Yoshiya I; Sasaki Y; Hori M; Hayashi N
J Gastroenterol Hepatol; 2001 Mar; 16(3):309-16. PubMed ID: 11339423
[TBL] [Abstract][Full Text] [Related]
33. HLA-A2-restricted cytotoxic T lymphocyte activity during interferon beta therapy in patients with chronic hepatitis C.
Ohira H; Iwasaki M; Takiguchi J; Rai T; Shishido S; Abe K; Takeda J; Tojo J; Sato Y; Kasukawa R
Fukushima J Med Sci; 2002 Dec; 48(2):75-83. PubMed ID: 12680611
[TBL] [Abstract][Full Text] [Related]
34. Inefficient recognition of autologous viral sequences by intrahepatic hepatitis C virus-specific cytotoxic T lymphocytes in chronically infected subjects.
Giuggio VM; Bonkovsky HL; Smith J; Rothman AL
Virology; 1998 Nov; 251(1):132-40. PubMed ID: 9813209
[TBL] [Abstract][Full Text] [Related]
35. Relation between viral fitness and immune escape within the hepatitis C virus protease.
Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
[TBL] [Abstract][Full Text] [Related]
36. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A
J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525
[TBL] [Abstract][Full Text] [Related]
37. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release.
Koziel MJ; Dudley D; Afdhal N; Grakoui A; Rice CM; Choo QL; Houghton M; Walker BD
J Clin Invest; 1995 Nov; 96(5):2311-21. PubMed ID: 7593618
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection.
Koziel MJ; Walker BD
Springer Semin Immunopathol; 1997; 19(1):69-83. PubMed ID: 9266632
[TBL] [Abstract][Full Text] [Related]
39. Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells.
Wedemeyer H; Mizukoshi E; Davis AR; Bennink JR; Rehermann B
J Virol; 2001 Dec; 75(23):11392-400. PubMed ID: 11689620
[TBL] [Abstract][Full Text] [Related]
40. Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions.
Sarobe P; Pendleton CD; Akatsuka T; Lau D; Engelhard VH; Feinstone SM; Berzofsky JA
J Clin Invest; 1998 Sep; 102(6):1239-48. PubMed ID: 9739058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
